Loading Ticker...

Archive for the 'Pharma' Category

USFDA approval for Lupin’s Suprax Oral Suspension

Lupin Pharma Logo

Drug Firm Lupin Ltd announced today that its subsidiary Lupin Pharmaceuticals has received approval from the United States Food and Drugs Administration (US FDA) for its Oral suspension – Suprax in the strength of 500mg/5mL. The company expects to start shipping the product in near future. Presently Suprax is available as 100 mg/5ml and 200 […]

Continue Reading...

Cipla to buy Cipla Medpro for Rs. 1100 Crores

Cipla Medpro Logo

Cipla has agreed to acquire South African drugmaker Cipla Medpro which makes the international business a lot bigger. With this acquisition this business in India makes up more than half of its quarterly revenues. For Cipla, South Africa now would become their second largest drug market. According to the chairman and manging director of the […]

Continue Reading...

Second facility in Malaysia by Ranbaxy Laboratories

Ranbaxy Logo

Ranbaxy Laboratories is doing well on its expansion plans as it set up a new manufacturing facility in Malaysia. This would not be its 2nd facility in the mentioned country. This project will serve as an entry point project by Ranbaxy Malaysia. The investment for this facility would reach up to $40 million and will […]

Continue Reading...

30 Telemedicine Units to be set up in Africa by Apollo Hospitals

Apollo Hospitals Logo

Apollo Hospitals BSE and AfroIndia Medical Services have agreed to create a memorandum regarding the set up of 30 telemedicine units in East and West Africa. This will surely be a big help to providing quality and fast health care to people in Africa.The move is a good sign that there are still people who […]

Continue Reading...

Serum Institute of India buys Dutch Vaccine maker Bilthoven for Rs. 22.5 Cr (Approx)

Serum Institute of India Logo

A top executive of Serum Institute of India said that the company had bought polio vaccine maker Bilthoven Biologicals from the government of Netherlands for a sum of US $40.3 Million (Which is approximately Rs. 25 crores in Indian Currency). This move will surely give them a stronger stand of being the country’s top vaccine […]

Continue Reading...

Diabetes Drugs Market Grows At 22% India – Diabetes problem getting worse!

Credit Suisse Logo

According to a Credit Suisse report, the domestic diabetes drugs market for the FY 2012 grew 22 per cent at $700 million. This might be good news to businesses that sells these drugs, but definitely not good news for the government that aims to have a healthy and safe people. This report just shows that […]

Continue Reading...

Boehringer-Eli Lilly Alliance Launches Anti-Diabetes Products In India

Two known companies when it comes to diabetes drugs would team up in order to bring its first product in Indian Market. These two companies are Boehringer Ingelheim and Eli Lilly. Among the products that will be introduced by Boehringer Ingelheim is Linagliptin which is a single dose tablet for Type 2 diabetes that is […]

Continue Reading...

Germany’s MDI Labs Sets Up Business In India; Targets Rs. 300 Cr Turnover By 2015

MDI which is the largest German clinical laboratory is entering the markets of India. The latter made an entry in the markets of India by setting up MDI Laboratories India Ltd. The company is planning to achieve a turnover of around Rs 300 crore by 2015. The said company aims to set up over 1,000 […]

Continue Reading...